A carregar...
Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide
Glioblastoma multiforme (GBM) is the most aggressive type of human primary brain tumor. The standard treatment protocol includes radiotherapy in combination with temozolomide (TMZ). Despite advances in GBM treatment, the survival time of patients diagnosed with glioma is 14.5 months. Regarding tumor...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5038559/ https://ncbi.nlm.nih.gov/pubmed/27698831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4992 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|